European Union Approves Phase 2 Trial Testing IFX-1 in AAV Patients – ANCA Vasculitis News

European Union Approves Phase 2 Trial Testing IFX-1 in AAV Patients – ANCA Vasculitis News

European Union Approves Phase 2 Trial Testing IFX-1 in AAV Patients – ANCA Vasculitis News
Published on 2019-01-07